Avenzo Therapeutics: Dualitybio to Be Eligible to Receive up to About $1.15 Bln in Development, Regulatory & Commercial Milestone Payments
Avenzo Therapeutics:Dualitybio有資格獲得約11.5億美元的發展、監管及商業里程碑付款
Avenzo Therapeutics: Dualitybio to Be Eligible to Receive up to About $1.15 Bln in Development, Regulatory & Commercial Milestone Payments
Avenzo Therapeutics:Dualitybio有資格獲得約11.5億美元的發展、監管及商業里程碑付款
使用瀏覽器的分享功能,分享給你的好友吧